New York State Common Retirement Fund’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-260,562
| Closed | -$47.9M | – | 3650 |
|
|
2021
Q2 | $47.9M | Sell |
260,562
-17,638
| -6% | -$3.03M | 0.05% | 335 |
|
|
2021
Q1 | $42.5M | Sell |
278,200
-90,942
| -25% | -$14.1M | 0.05% | 359 |
|
|
2020
Q4 | $57.7M | Sell |
369,142
-129,381
| -26% | -$16.6M | 0.06% | 282 |
|
|
2020
Q3 | $57M | Sell |
498,523
-1,410
| -0.3% | -$152K | 0.07% | 256 |
|
|
2020
Q2 | $56.1M | Sell |
499,933
-141,262
| -22% | -$15M | 0.07% | 265 |
|
|
2020
Q1 | $57.6M | Sell |
641,195
-19,409
| -3% | -$1.9M | 0.09% | 213 |
|
|
2019
Q4 | $71.4M | Sell |
660,604
-11,570
| -2% | -$1.24M | 0.08% | 222 |
|
|
2019
Q3 | $65.8M | Buy |
672,174
+7,434
| +1% | +$838K | 0.08% | 232 |
|
|
2019
Q2 | $87.1M | Sell |
664,740
-3,261
| -0.5% | -$420K | 0.11% | 192 |
|
|
2019
Q1 | $90.3M | Buy |
668,001
+47,506
| +8% | +$5.91M | 0.12% | 167 |
|
|
2018
Q4 | $60.4M | Sell |
620,495
-8,256
| -1% | -$976K | 0.09% | 219 |
|
|
2018
Q3 | $87.4M | Buy |
628,751
+25,642
| +4% | +$3.22M | 0.1% | 190 |
|
|
2018
Q2 | $74.9M | Buy |
603,109
+37,461
| +7% | +$4.38M | 0.09% | 202 |
|
|
2018
Q1 | $63M | Sell |
565,648
-11,599
| -2% | -$1.39M | 0.08% | 244 |
|
|
2017
Q4 | $69M | Buy |
577,247
+10,698
| +2% | +$1.3M | 0.08% | 230 |
|
|
2017
Q3 | $79.5M | Hold |
566,549
| – | – | 0.1% | 203 |
|
|
2017
Q2 | $68.9M | Sell |
566,549
-10,585
| -2% | -$1.23M | 0.09% | 219 |
|
|
2017
Q1 | $70M | Sell |
577,134
-3,195
| -0.6% | -$412K | 0.09% | 212 |
|
|
2016
Q4 | $71M | Buy |
580,329
+12,280
| +2% | +$1.5M | 0.1% | 197 |
|
|
2016
Q3 | $69.6M | Sell |
568,049
-54,404
| -9% | -$7M | 0.1% | 197 |
|
|
2016
Q2 | $72.7M | Buy |
622,453
+22,369
| +4% | +$3.17M | 0.11% | 187 |
|
|
2016
Q1 | $83.5M | Sell |
600,084
-40,400
| -6% | -$5.93M | 0.13% | 156 |
|
|
2015
Q4 | $122M | Sell |
640,484
-22,050
| -3% | -$3.85M | 0.19% | 106 |
|
|
2015
Q3 | $104M | Buy |
662,534
+2,794
| +0.4% | +$510K | 0.16% | 122 |
|
|
2015
Q2 | $119M | Buy |
659,740
+39,059
| +6% | +$6.74M | 0.17% | 118 |
|
|
2015
Q1 | $108M | Buy |
620,681
+10,902
| +2% | +$1.97M | 0.16% | 134 |
|
|
2014
Q4 | $113M | Sell |
609,779
-65,754
| -10% | -$12.2M | 0.17% | 130 |
|
|
2014
Q3 | $112M | Sell |
675,533
-16,413
| -2% | -$2.7M | 0.17% | 122 |
|
|
2014
Q2 | $108M | Buy |
691,946
+65,416
| +10% | +$10.3M | 0.16% | 130 |
|
|
2014
Q1 | $95.3M | Buy |
626,530
+59,450
| +10% | +$9.45M | 0.15% | 143 |
|
|
2013
Q4 | $75.5M | Sell |
567,080
-61,000
| -10% | -$7.32M | 0.12% | 179 |
|
|
2013
Q3 | $73M | Sell |
628,080
-12,220
| -2% | -$1.34M | 0.12% | 167 |
|
|
2013
Q2 | $59.1M | Buy |
+640,300
| New | +$61.7M | 0.1% | 200 |
|
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM